Aligos Therapeutics Initiates Dosing In Healthy Volunteers With siRNA Drug Candidate ALG-125755

October 14, 2022

https://www.globenewswire.com/news-release/2022/10/14/2534606/0/en/Aligos-Therapeutics-Initiates-Dosing-In-Healthy-Volunteers-With-siRNA-Drug-Candidate-ALG-125755.html

Single ascending doses to be evaluated in healthy volunteers in Q4 2022

Single ascending doses to be evaluated in subjects with chronic hepatitis B beginning in Q1 2023

Read more at globenewswire.com

Related news for (ALGS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.